WHY US

Partner with us for Press release distribution and get best in class service, guaranteed postings on tier 1 media and maximum reach

Aragen Announces Partnership with Skyhawk Therapeutics, Aimed at Developing Novel Small Molecule Therapeutics that Correct RNA Expression

  • Thursday, July 15, 2021 12:00PM IST (6:30AM GMT)
 
Hyderabad, Telangana, India:  Aragen Life Sciences (formerly, GVK BIO), a leading Contract Research and Development Organization (CRDO), headquartered out of Hyderabad, India, announced that it has been selected by Skyhawk Therapeutics, a leader in the development of small molecule therapeutics that correct RNA expression, as its partner in India. Through this collaboration, Aragen will provide Skyhawk with various discovery chemistry and biology service solutions.
 
This partnership is focused on accelerating Skyhawk’s research pipeline. “We are delighted to have been selected by Skyhawk Therapeutics as its partner in India. At Aragen, we believe that in every molecule is the possibility for better health. It is with this spirit that we look forward to leveraging Aragen’s 20 years of discovery research expertise to help Skyhawk advance the development of its novel small molecule therapeutics targeting some of the world’s most intractable diseases,” said Manni Kantipudi, CEO of Aragen.


About Aragen Life Sciences

Aragen Life Sciences Pvt Ltd (Aragen) is a global leader in providing discovery, development and manufacturing solutions for life sciences firms. With a team of over 3100 professionals, and through a network of sites around the world, we offer a seamless, integrated platform to advance customer programs from discovery through commercialization for both small molecules and biologics. Established in 2001, Aragen now serves over 450 customers worldwide across multiple modalities and therapeutic areas.
Click here for Media Contact Details

Sarat Patanaik, Aragen Life Sciences, [email protected], +91-9573280064

Bhavna Pathak, MediaMedic Communications Pvt. Ltd., [email protected], +91-8830654608

Submit your press release

Copyright © 2021 Business Wire India. All Rights Reserved.